The establishment of the first ex vivo whole organ model for human liver neoplasms

Qiang Zhao; Jingjing Li; Caihui Zhu; Honghui Chen; Yihao Ma; Weixin Luo; Rongxing Xie; Yixi Zhang; Xiaobo Wang; Linhe Wang; Zhiheng Zhang; Zhiyong Guo; Xiaoshun He

doi:10.1101/2020.07.05.20146290

Abstract

Background The incidence of liver neoplasms is on the leading rise worldwide due to lacking exact research model. Accordingly, the resected diseased liver within cancer during liver transplantation was the appropriated model, therefore the aim of this study was to establish the first ex vivo whole organ model for liver neoplasms by using normothermic perfusion system named Life-X system.

Materials and Methods Four diseased livers within cancer resected during liver transplantation were collected for research. The common hepatic artery and portal vein of the ex vivo liver were connected to the Life-X perfusion device that circulated Life-X perfusate providing continuous oxygen and nutrient supply. The flow and pressure of the perfusate was recorded and blood gas analysis was examined to analyze the function of the diseased liver. Liver tissues after perfusion were collected for histological analysis.

Results Experiments showed that the artery and portal vein flow were stable 1h after perfusion and were kept within the physiological range. The results of blood gas analysis demonstrated restoration and maintenance of metabolism. Moreover, the bile production of diseased Case 4 liver represented its vivid functionality during the entire 47h of perfusion. Histology analysis shows little liver injury after the perfusion.

Conclusions Therefore, we have established a powerful tool to research liver neoplasms in vitro through Life-X perfusion system.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Our research was supported by the National Natural Science Foundation of China (81970564, 81471583, 81570587 and 81700557), the Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology (2013A061401007 and 2017B030314018), Guangdong Provincial Natural Science Funds for Major Basic Science Culture Project (2015A030308010), Guangdong Provincial Natural Science Funds for Distinguished Young Scholars (2015A030306025), Special Support Program for Training High Level Talents in Guangdong Province (2015TQ01R168), Science and Technology Program of Guangzhou (201704020150), the Natural Science Foundations of Guangdong province (2016A030310141 and 2020A1515010091) and Young Teachers Training Project of Sun Yat-sen University (K0401068).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the Ethical Committee of The First Affiliated Hospital of Sun Yat-sen University, and informed consent was obtained from the participant.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes